As of June 21, 2025, Antisense Therapeutics Ltd (ANP.AX) reports a Graham Number of N/A.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Antisense Therapeutics Ltd's Graham Number
Over recent years, Antisense Therapeutics Ltd's Graham Number has shown limited historical data. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2023-06-30 | - |
| 2022-06-30 | 0.01 |
This trend highlights how Antisense Therapeutics Ltd manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Antisense Therapeutics Ltd's Graham Number to Peers
To better understand Antisense Therapeutics Ltd's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Antisense Therapeutics Ltd (ANP.AX) | - |
| GL Pharm Tech Corp (204840.KQ) | 267.29 |
| Neuren Pharmaceuticals Ltd (NEU.AX) | 8.61 |
| Little Green Pharma Ltd (LGP.AX) | 0.26 |
| IDT Australia Ltd (IDT.AX) | 0.16 |
| Invex Therapeutics Ltd (IXC.AX) | 0.05 |
Compared to its competitors, Antisense Therapeutics Ltd's Graham Number is difficult to compare due to insufficient data.